24 mai 2023
bartosb, « Incentivising drug development for paediatric cancers in Europe », ELSIBI, ID : 10670/1.jgzdye
A recent study published in Cancer Medicine proposes strategies which could help incentivise the development of drugs specifically intended for paediatric cancers in Europe and the United States. While such incentives already exist for both paediatrics and rare diseases, these have not been sufficient when it comes to therapeutics for childhood cancers. Instead, their development has remained largely dependent on adult cancers and their potential markets, which fails to adequately address the...